Effect of decreased renal function on the pharmacokinetics of ceftazidime
- PMID: 6378087
- PMCID: PMC185645
- DOI: 10.1128/AAC.25.6.785
Effect of decreased renal function on the pharmacokinetics of ceftazidime
Abstract
The pharmacokinetics of ceftazidime after a 1-g bolus dose were studied in 11 subjects, with creatinine clearances ranging from 113 to 6 ml/min. Concentrations of ceftazidime in serum were determined by microbiological assay. These data were fitted to a two-compartment open model, and pharmacokinetic parameters were calculated. Correlation of ceftazidime clearance with creatinine clearance was excellent (r = 0.99).
Similar articles
-
Pharmacokinetics of ceftazidime in patients with renal insufficiency.Antimicrob Agents Chemother. 1984 Feb;25(2):201-4. doi: 10.1128/AAC.25.2.201. Antimicrob Agents Chemother. 1984. PMID: 6370127 Free PMC article.
-
Pharmacokinetics of ceftazidime in normal and uremic subjects.Antimicrob Agents Chemother. 1984 May;25(5):638-42. doi: 10.1128/AAC.25.5.638. Antimicrob Agents Chemother. 1984. PMID: 6375562 Free PMC article.
-
Pharmacokinetics of cefmetazole in normal subjects and in patients with impaired renal function.Antimicrob Agents Chemother. 1980 Sep;18(3):386-9. doi: 10.1128/AAC.18.3.386. Antimicrob Agents Chemother. 1980. PMID: 6932824 Free PMC article.
-
Pharmacokinetics of cephalosporins in patients with normal or reduced renal function.J Infect Dis. 1978 May;137 Suppl:S88-S99. doi: 10.1093/infdis/137.supplement.s88. J Infect Dis. 1978. PMID: 349098 Review.
-
Pharmacokinetics of cefoperazone in patients with normal and impaired hepatic and renal function.Rev Infect Dis. 1983 Mar-Apr;5 Suppl 1:S127-36. doi: 10.1093/clinids/5-supplement_1.s127. Rev Infect Dis. 1983. PMID: 6221382 Review.
Cited by
-
Clinical pharmacokinetics of the third generation cephalosporins.Clin Pharmacokinet. 1985 Mar-Apr;10(2):101-43. doi: 10.2165/00003088-198510020-00001. Clin Pharmacokinet. 1985. PMID: 3888488 Review.
-
Population pharmacokinetics of continuous infusion ceftazidime.Clin Pharmacokinet. 1999 Oct;37(4):343-50. doi: 10.2165/00003088-199937040-00005. Clin Pharmacokinet. 1999. PMID: 10554049 Clinical Trial.
-
Correlation of the pharmacokinetic parameters of amikacin and ceftazidime.Clin Pharmacokinet. 2007;46(10):859-66. doi: 10.2165/00003088-200746100-00004. Clin Pharmacokinet. 2007. PMID: 17854235 Clinical Trial.
-
Comparative pharmacokinetics of ceftazidime in young, healthy and elderly, acutely ill males.Eur J Clin Pharmacol. 1988;34(2):179-86. doi: 10.1007/BF00614556. Eur J Clin Pharmacol. 1988. PMID: 3289950
-
Pharmacokinetic/Pharmacodynamic Target Attainment of Ceftazidime in Adult Patients on General Wards with Different Degrees of Renal Function: A Prospective Observational Bicenter Cohort Study.Antibiotics (Basel). 2023 Feb 25;12(3):469. doi: 10.3390/antibiotics12030469. Antibiotics (Basel). 2023. PMID: 36978336 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical